Page 271 - பல்கலைக்கழகம் ஆஃப் சிகாகோ மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail Uterine fibroids are a common cause of heavy menstrual bleeding and pain in women of reproductive age, especially among women of color. An estimated $34 billion in healthcare costs are associated with uterine fibroids in the United States alone each year, yet there are few treatment options other than surgery. Now a University of Chicago Medicine researcher working with an international team of scientists has developed a daily oral combination therapy that is reliable, safe and effective for long-term treatment of uterine fibroids. This discovery is an important new tool that will be an important addition to the field, said Ayman Al-Hendy, MD, PhD, a professor of obstetrics and gynecology and lead author of the study, which was published February 17, 2021 in the

United statesNorth carolinaRoberta venturellaClaudio villarroelLaura mckainRachelb wagmanJuanc arjona ferreiraElizabetha stewartAndreas lukesAndriagm langenbergHilary od critchleyYulan liAlfredn poindexterAyman al hendyUniversity of chileCarolina women research